Skip to main content
Dr. Miltie  |  Clinical technology for care wherever it happens. Need funding? Explore Atlas by Dr. Miltie (opens in a new tab)
•American Heart Association (AHA)

Infant Interstage Home Monitoring: American Heart Association 2020 Findings

Historical clinical research context (August 2020): This article discusses an August 11, 2020 American Heart Association announcement and the scientific statement by Nancy A. Rudd and colleagues (DOI: 10.1161/JAHA.119.014548). The cited roughly 40% mortality reduction and improvement in growth outcomes relate to historical interstage quality-improvement data for infants with single-ventricle heart disease. These findings are associations, not proof that monitoring alone caused the outcomes; they do not apply to all pediatric telehealth programs. This is not individualized clinical guidance.

A 2020 American Heart Association scientific statement described an approximately 40 percent decline in interstage mortality in a multicenter quality-improvement initiative for infants with certain single-ventricle heart defects. The reported association does not establish that home monitoring alone caused the change.

In a scientific statement published in the latest edition of the Journal of the American Heart Association, researchers found that an interstage home monitoring (IHM) program, which gives parents mHealth tools and instructs them on how to monitor important health parameters including an infant’s oxygen saturation levels, caloric intake and weight gain, played a significant role in improving overall health outcomes.

The program also trained parents to identify certain warning signs, such as respiratory changes, sweating, fussiness, diarrhea, fever or changes in skin color, and notify the care team immediately.

The 2020 scientific statement led by Nancy Rudd, MS, CPNP-PC/AC, summarized interstage home monitoring experiences at pediatric cardiac centers, including more hospitalizations for observation or limited interventions and fewer readmissions for major adverse events in reported programs. These are observational findings, not results of a randomized trial.

The American Heart Association reported a decrease in growth failure rates, from 18.6 percent to 13.1 percent, in historical multicenter quality-improvement data. This does not mean that individual infants gained 28 percent more weight, nor does it establish that telehealth alone caused the improvement.

“Prior to interstage home monitoring programs, the outpatient management of interstage infants was the same as that of much less complex patients,” Rudd said in an AHA press release. “Unfortunately, the tenuous nature of these infants means they can get very sick very quickly from even minor childhood illness like the common cold.”

Children’s Wisconsin implemented its IHM program in 2000, according to the release, following a study that found mortality rates as high as 16 percent in infants recovering from surgery for heart defects.

The scientific statement discussed outcomes from the National Pediatric Cardiology Quality Improvement Collaborative, which involved approximately 50 participating cardiac centers during 2008–2016.

“IHM is an innovative strategy developed to augment conventional outpatient management and to assist with early detection of physiologic changes associated with morbidity and mortality following successful (surgery),” she concluded in her report. “There is overwhelming evidence of improvement in single ventricle infant survival and growth outcomes with IHM programs.”

“This surveillance strategy has become the standard of care for most pediatric cardiac programs and continues to evolve using telehealth platforms such as phone technology and tablet‐based real‐time video encounters in an effort to optimize data collection and visual assessment of the infant at home,” she added. 

Move from information to action

See how the N9+ can fit your organization.

Explore the remote physical exam platform or request a focused demonstration.